<i>Abiotrophia</i> spp. and <i>Staphylococcus epidermidis</i> Endocarditis Treated with Daptomycin

doi:10.1100/tsw.2008.95

Journal Menu

About this Journal
Abstracting and Indexing
Aims and Scope
Article Processing Charges
Articles in Press
Author Guidelines
Bibliographic Information
Citations to this Journal
Contact Information
Editorial Board
Editorial Workflow
Free eTOC Alerts
Publication Ethics
Submit a Manuscript
Subscription Information
Table of Contents

Open Special Issues
Published Special Issues
Special Issue Guidelines

Abstract
Full-Text PDF
How to Cite this Article

TheScientificWorldJOURNAL
Volume 8 (2008), Pages 793-795
doi:10.1100/tsw.2008.95

Case Study

Abiotrophia spp. and Staphylococcus epidermidis Endocarditis Treated with Daptomycin

E. Bishburg,¹ D. Ghuman,² A. Cohen,² T. Chan,³ and S. Nalmas¹

¹Division of Infectious Diseases, Newark Beth Israel Medical Center, Newark, NJ, USA
²Division of Hematology-Oncology, Newark Beth Israel Medical Center, Newark, NJ, USA
³Division of Pathology, Newark Beth Israel Medical Center, Newark, NJ, USA

Received 6 March 2008; Accepted 30 June 2008

Academic Editor: Arthur M. Feldman

Abstract

Endocarditis due to Abiotrophia spp. occurs in about 5% of endocarditis cases. Most of the cases respond to a combination of penicillin and gentamicin, or vancomycin. We describe a case of Staphylococcus epidermidis (CONS) and Abiotrophia spp. endocarditis that failed vancomycin treatment, but responded to daptomycin and rifampin.